FDA Clears New Contrast-Enhanced Breast Imaging Capabilities for Mammomat B.brilliant
The newly cleared contrast-enhanced mammography and biopsy capabilities aim to help radiologists characterize suspicious findings and perform targeted biopsies more efficiently.
